BUR1

CAS No. 23000-46-6

BUR1( BUR-1 | BUR 1 | BMP upregulator 1 | BMP upregulator-1 )

Catalog No. M27759 CAS No. 23000-46-6

BUR1 is a Saccharomyces cerevisiae cyclin-dependent kinase (CDK) and is homologous to mammalian Cdk9, which functions in transcriptional elongation.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 302 In Stock
5MG 319 In Stock
10MG 472 In Stock
25MG 753 In Stock
50MG 1051 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BUR1
  • Note
    Research use only, not for human use.
  • Brief Description
    BUR1 is a Saccharomyces cerevisiae cyclin-dependent kinase (CDK) and is homologous to mammalian Cdk9, which functions in transcriptional elongation.
  • Description
    BUR1 is a Saccharomyces cerevisiae cyclin-dependent kinase (CDK) and is homologous to mammalian Cdk9, which functions in transcriptional elongation.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    BUR-1 | BUR 1 | BMP upregulator 1 | BMP upregulator-1
  • Pathway
    Angiogenesis
  • Target
    CDK
  • Recptor
    SETD2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    23000-46-6
  • Formula Weight
    279.347
  • Molecular Formula
    C16H17N5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C1CCN(CC1)c1ncnc2n(ncc12)-c1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Jennifer Totman, et al. Pharmacologic Inhibition of the Histone Methyltransferase SETD2 with EZM0414 As a Novel Therapeutic Strategy in Relapsed or Refractory Multiple Myeloma and Diffuse Large B-cell Lymphoma.
molnova catalog
related products
  • PF-562271

    PF-562271 is a potent, ATP-competitive, reversible inhibitor of FAK with IC50 of 1.5 nM in cell-free assays.

  • AZD 5597

    A highly potent cyclin-dependent kinase (CDK) inhibitor with IC50 of 2 nM for both CDK1 and CDK2; exhibits anti-proliferative activity against LoVo cells with IC50 of 39 nM.

  • ON123300

    ON123300 is a potent, multi-targeted kinase inhibitor with IC50 of 5, 3.9, 26, 26, 9.2 and 11 nM for ARK5, CDK4, PDGFRβ, FGFR1, RET and FYN, respectively.